Lentivirus Production Using Calcium Phosphate or Lipofectamine

Lentivirus was produced using Calcium phosphate (Takara Bio, Mountain View, CA) or Lipofectamine (Invitrogen, Carlsbad, CA) as described (15 (link)).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

O’Neal J., Ritchey J.K., Cooper M.L., Niswonger J., Sofía González L., Street E., Rettig M.P., Gladney S.W., Gehrs L., Abboud R., Prior J.L., Haas G.J., Jayasinghe R.G., Ding L., Ghobadi A., Vij R, & DiPersio J.F. (2022). CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. Leukemia, 36(6), 1625-1634.

Publication 2022

Calcium phosphate Lipofectamine

Calcium phosphate Lentivirus Lipofectamine

Corresponding Organization : Washington University in St. Louis

Top 5 similar protocols

Variable analysis

independent variables

Calcium phosphate (Takara Bio, Mountain View, CA)
Lipofectamine (Invitrogen, Carlsbad, CA)

dependent variables

Not explicitly mentioned

control variables

Not explicitly mentioned

controls

Not specified
Not specified

Annotations

This protocol is too short. Unable to provide accurate annotations

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!